iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide

C46H37FeN9O5 — CID 20603255

IUPACiron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide
SMILESO=C(NCCCCc1cccc(O)c1)c1cccc2c1-c1nc-2nc2[n-]c(nc3nc(nc4[n-]c(n1)c1ccc(CO)cc41)-c1cc(CO)ccc1-3)c1c2CC=C(CO)C1.[Fe+2]
InChIInChI=1S/C46H38N9O5.Fe/c56-21-25-10-13-29-34(18-25)42-49-38(29)48-41-32-8-4-9-33(46(60)47-16-2-1-5-24-6-3-7-28(59)17-24)37(32)45(55-41)54-40-31-15-12-27(23-58)20-36(31)44(52-40)53-43-35-19-26(22-57)11-14-30(35)39(50-42)51-43;/h3-4,6-12,14-15,17,19-20,56-58H,1-2,5,13,16,18,21-23H2,(H3-,47,48,49,50,51,52,53,54,55,59,60);/q-1;+2/p-1
InChIKeyOQKQWZCRFBLVFV-UHFFFAOYSA-M
MW851.70 g/mol
LogP5.43
Rot. Bonds9

About iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide

iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide (PubChem CID 20603255) has the molecular formula C46H37FeN9O5 and a molecular weight of 851.70 g/mol. Its IUPAC name is iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide.

Molecular Properties

Compound Nameiron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide
PubChem CID20603255
Molecular FormulaC46H37FeN9O5
Molecular Weight851.70 g/mol
Exact Mass851.23
IUPAC Nameiron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide
SMILESO=C(NCCCCc1cccc(O)c1)c1cccc2c1-c1nc-2nc2[n-]c(nc3nc(nc4[n-]c(n1)c1ccc(CO)cc41)-c1cc(CO)ccc1-3)c1c2CC=C(CO)C1.[Fe+2]
InChIInChI=1S/C46H38N9O5.Fe/c56-21-25-10-13-29-34(18-25)42-49-38(29)48-41-32-8-4-9-33(46(60)47-16-2-1-5-24-6-3-7-28(59)17-24)37(32)45(55-41)54-40-31-15-12-27(23-58)20-36(31)44(52-40)53-43-35-19-26(22-57)11-14-30(35)39(50-42)51-43;/h3-4,6-12,14-15,17,19-20,56-58H,1-2,5,13,16,18,21-23H2,(H3-,47,48,49,50,51,52,53,54,55,59,60);/q-1;+2/p-1
InChIKeyOQKQWZCRFBLVFV-UHFFFAOYSA-M
XLogP5.43
TPSA215.56 Ų
H-Bond Donors5
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms61
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500851.70
LogP ≤ 55.43
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
The IUPAC name of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide (CID 20603255) is iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide.
What is the SMILES notation for iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
The canonical SMILES for iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide is O=C(NCCCCc1cccc(O)c1)c1cccc2c1-c1nc-2nc2[n-]c(nc3nc(nc4[n-]c(n1)c1ccc(CO)cc41)-c1cc(CO)ccc1-3)c1c2CC=C(CO)C1.[Fe+2].
What is the InChIKey of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
The InChIKey is OQKQWZCRFBLVFV-UHFFFAOYSA-M. The full InChI is InChI=1S/C46H38N9O5.Fe/c56-21-25-10-13-29-34(18-25)42-49-38(29)48-41-32-8-4-9-33(46(60)47-16-2-1-5-24-6-3-7-28(59)17-24)37(32)45(55-41)54-40-31-15-12-27(23-58)20-36(31)44(52-40)53-43-35-19-26(22-57)11-14-30(35)39(50-42)51-43;/h3-4,6-12,14-15,17,19-20,56-58H,1-2,5,13,16,18,21-23H2,(H3-,47,48,49,50,51,52,53,54,55,59,60);/q-1;+2/p-1.
What are the key properties of iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide?
iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide has a molecular weight of 851.70 g/mol, XLogP of 5.43, 9 rotatable bonds, 5 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for iron(2+);16,25,33-tris(hydroxymethyl)-N-[4-(3-hydroxyphenyl)butyl]-2,11,20,29,38,40-hexaza-37,39-diazanidanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1,3(40),4(9),5,7,10,12,15,18,20,22(27),23,25,28(38),29,31(36),32,34-octadecaene-5-carboxamide is sourced from PubChem (CID 20603255), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).